Pediatrics
Showing 651-700 of 1,596 Results
-
Yingying Jin
Postdoctoral Scholar, Human Gene Therapy
BioYingying is a postdoctoral researcher at Kay Lab. She completed her PhD at Peking Union Medical College in China in 2024, under the supervision of Prof. De-Pei Liu. Her research focused on gene editing and ssDNA-protein interactions. During her PhD, she developed an innovative strategy to enhance HDR efficiency of ssDNA donors by incorporating HDR-boosting modules. In 2025, she joined Kay Lab, where her current work involves improving exogenous gene expression delivered by AAV through engineering the AAV genome.
-
Claire Johns
Clinical Assistant Professor, Pediatrics - Hematology & Oncology
BioFellowship: Pediatric Hematology Oncology Fellowship, Stanford Lucile Packard Children's Hospital 2022-2025
Residency: Pediatrics, University of California San Francisco 2019-2022
Medical School: University of California San Francisco, Class of 2019 -
Jamie S. Johnston
Research and Evaluation Director, Stanford Center for Health Education, Pediatrics - Infectious Diseases
BioJamie Johnston is the Research and Evaluation Director for the Stanford Center for Health Education. Her work focuses on the use of technology to improve educational access and health education in under-resourced areas. Jamie completed a PhD in Economics of Education at the Stanford Graduate School of Education in 2017, where she was an Institute of Education Sciences (IES) doctoral fellow. She also completed a postdoctoral fellowship with Stanford School of Medicine. Additionally, Jamie holds a BS in Social Policy from Northwestern University, an MPP from the University of Chicago, and an MA in Economics from Stanford University.
-
Noelle V Johnstone
Clinical Instructor, Pediatrics - General Pediatrics
Current Research and Scholarly InterestsPediatric Hospital Medicine, Quality and Safety, Resident and Medical Student Education, Medical Humanities, International Child Health
-
Neha Shirish Joshi, MD MS
Instructor, Pediatrics
BioNeha S Joshi, MD MS is an Instructor in the Division of Pediatric Hospital Medicine at Stanford University. Her clinical responsibilities include caring for hospitalized children at Lucile Packard Children’s Hospital Stanford as a board certified Pediatric Hospitalist, and neonatal resuscitation and the care of level I/II late preterm and term newborns as a Neonatal Hospitalist. Dr. Joshi completed her MD with Distinction at the University of California San Francisco, followed by both residency in Pediatrics and fellowship in Pediatric Hospital Medicine at Stanford University. Dr. Joshi additionally completed a Masters in Clinical Research and Epidemiology at Stanford University. Her research program seeks to identify and implement high value care practices for late preterm and term infants during the birth hospitalization. Dr. Joshi's prior work has included the development of a clinical examination-based approach to identifying late preterm and term infants at risk for early onset sepsis; this work won the Jennifer Daru Memorial Award for manuscript with most potential to impact clinical care. Her current focus is the development of clinical benchmarks and quality markers for the care of late preterm infants during the birth hospitalization. Dr Joshi is presently supported by a NIH K23 Career Development Award, the Stanford Maternal and Child Health Research Institute, and the Society for Pediatric Research.
-
Shashank V. Joshi, MD
Professor (Teaching) of Psychiatry and Behavioral Sciences (Child and Adolescent Psychiatry and Child Development) and, by courtesy of Pediatrics and, of Education
Current Research and Scholarly InterestsDr. Joshi's teaching and research focuses on increasing knowledge and effectiveness of school mental health, youth wellbeing, positive psychology, pediatric psychotherapy and medication interventions. Areas of study include: the therapeutic alliance in medical care, structured psychotherapy interventions, cultural issues in pediatrics, wellbeing promotion and suicide prevention in schools settings, and faculty development in graduate medical education.
-
Saraswati Kache
Clinical Professor, Pediatrics - Critical Care
BioDr. Kache is a Clinical Professor of Pediatrics in the Division of Critical Care Medicine whose work spans pediatric transport, device innovation, global health, and sustainability. A recent Stanford Biodesign Faculty Fellow and recognized educator with multiple teaching awards, she is engaged in device development, building on a career devoted to critically ill children through innovation, education, and global collaboration.
She chairs the Sepsis Steering Committee at LPCH, which she helped launch in 2017 to develop a hospital-specific pathway from international guidelines, identify improvement opportunities, and drive better outcomes through education and evaluation of clinical data. She previously served on the American College of Critical Care Medicine committee that authored the Pediatric Sepsis Guidelines, shaping national and international standards.
As Medical Director of the Transport Program, she focuses on team education and standardized processes to build a high-functioning pediatric critical care transport team dedicated to safe inter-facility transport of critically ill children. She is also partnering with the American Academy of Pediatrics on a national multidisciplinary pediatric transport curriculum.
As a Stanford Innovations in Global Health Faculty Fellow, she founded the pediatric residency's Global Health Track to train physicians in equitable, sustainable pediatric care. Internationally, she has helped establish and support PICUs in Nepal, Uganda, and Zimbabwe, introduced CPAP in low-resource settings, and led PICU education and capacity-building to strengthen critical care infrastructure.
A member of the Maternal Child Health Research Institute, her research integrates guideline development, systems improvement, and global implementation of evidence-based pediatric critical care. She has recently begun examining how healthcare systems affect climate change and how to improve sustainability. -
Julia Kaltschmidt
Professor of Neurosurgery
Current Research and Scholarly InterestsThe lab’s primary research interest is to understand how specific neuronal circuits are established. We use mouse genetics, combinatorial immunochemical labeling and high-resolution laser scanning microscopy to identify, manipulate, and quantitatively analyze synaptic contacts within the complex neuronal milieu of the spinal cord and the enteric nervous system.
-
Jennifer Kang
Academic Prog Prof 2, Pediatrics - Infectious Diseases
Current Role at StanfordProgram Manager, Global Child Health Program
-
Cynthia Kapphahn
Clinical Professor, Pediatrics - Adolescent Medicine
Current Research and Scholarly InterestsAccess to health care services for adolescents.
Confidentiality.
Mental Health Financing.
Eating disorders. -
Siva Kasinathan
Instructor, Pediatrics - Rheumatology
BioSiva Kasinathan, MD, PhD, is a physician-scientist and Instructor of Pediatric Rheumatology at the Stanford University School of Medicine and Lucile Packard Children's Hospital. In addition to caring for children and young adults with rheumatic diseases in his clinical practice, Siva conducts research to advance the understanding of mechanisms of autoimmunity and autoinflammation.
Siva holds an MD and a PhD in Molecular and Cell Biology from the University of Washington, where he developed high-throughput methods for epigenome profiling and contributed new insights in chromatin biology and gene regulation. During his clinical training in pediatrics and rheumatology at Stanford, he pioneered approaches for single-molecule analysis of genetic variation, DNA methylation, and chromatin structure.
Siva's current research bridges genomics and immunology with a focus on developing and applying sensitive technologies to unravel the genetic and molecular underpinnings of lupus, arthritis, and other disorders of immune regulation. Siva is committed to translating fundamental discoveries into precision therapies and biomarkers to improve outcomes for patients with immune-mediated diseases. -
Aanchal Preet Kaur
Postdoctoral Scholar, Hematology-Oncology
BioDr. Aanchal Preet Kaur is a post-doctoral fellow in the Ramakrishna lab interested in understanding the role of myeloid cells in driving immunosuppression and resistance to CAR T cell therapies in pediatric patients with diffuse midline glioma. Her work involves developing organoid models to study the interaction of myeloid cells and CAR T cells and further employ these models to validate targets identified in patient single cell sequencing data using CRISPR technology.
Dr. Aanchal Preet Kaur received her PhD in Oncology at the University of Nottingham, United Kingdom where she focused on developing dendritic cell vaccines for melanoma. In her earlier post-doctoral work at Providence Cancer Institute with Dr. Michael Gough, she developed spheroid models to study the impact of radiation therapy on immune cell-cancer cell interactions. -
Mark A. Kay, M.D., Ph.D.
Dennis Farrey Family Professor of Pediatrics, and Professor of Genetics
Current Research and Scholarly InterestsMark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.
-
John Kerner
Professor of Pediatrics (Gastroenterology), Emeritus
Current Research and Scholarly InterestsI am interested in pediatric nutritional support and have experience evaluating new enteral and parenteral products especially for the neonate (I studied a "new" I.V. fat product for Abbott; I participated in a multicenter trial of a formula with fish oil in it for neonates with Mead Johnson and a multicenter trial of a new human milk fortifier for Wyeth).
-
Kian Keyashian
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioThe management of inflammatory bowel disease continues to evolve, with the introduction of biologic and small molecule therapies and new goals of treatment, with an emphasis on healing the bowel. My career goal since my graduation from IBD fellowship in 2012 has been to improve the outcomes and quality of life of patients with inflammatory bowel disease. In line with these goals, my research has focused investigating new noninvasive diagnostic test, finding factors early in the disease course that might predict a more aggressive disease course and need for different therapies, and investigating new promising effective medications with less side effects.
